Axsome Therapeutics, Inc. (AXSM)
175.38
-1.44
(-0.81%)
USD |
NASDAQ |
Jan 13, 14:56
Axsome Therapeutics Research and Development Expense (Annual): 186.54M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Corcept Therapeutics, Inc. | 246.89M |
| Gilead Sciences, Inc. | 5.816B |
| Vanda Pharmaceuticals, Inc. | 74.43M |
| Madrigal Pharmaceuticals, Inc. | 235.62M |
| Innoviva, Inc. | 13.65M |